Mutation of the LEPR Gene at Reunion Island: Involvement in Pediatric Obesity

NCT04329260 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2021-01-27

No results posted yet for this study

Summary

The objective of this study is to estimate the proportion of the recurrent deletion Δ6-8 of the LEPR gene in the homozygous and heterozygous state in pediatric cases with severe and early ( before the age of 6) obesity (BMI ≥ IOTF-30) on Reunion Island.

Conditions

  • Obesity, Childhood

Sponsors & Collaborators

  • Centre Hospitalier Universitaire de la Réunion

    lead OTHER

Principal Investigators

  • Paul GUEGUEN, MD · CHU de La Réunion

Eligibility

Min Age
3 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-03-31
Primary Completion
2022-06-30
Completion
2022-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04329260 on ClinicalTrials.gov